Abiopharma

🔍 BOBO DONALD E JR (Executive)

Company: Edwards Lifesciences Corp (EW)

Report Date: 2025-12-12

Detailed Transactions and Holdings:

• Sold 5,486 shares of Common Stock at $83.79 per share (Direct)
  Date: 2025-12-12 | Code: S | equity_swap_involved: 0 | shares_owned_after: 44,870.25 | transaction_form_type: 4
• Sold 5,900 shares of Common Stock at $83.74 per share (Direct)
  Date: 2025-12-12 | Code: S | equity_swap_involved: 0 | shares_owned_after: 38,970.25 | transaction_form_type: 4
• Sold 7,100 shares of Common Stock (Direct)
  Date: 2025-12-12 | Code: G | equity_swap_involved: 0 | shares_owned_after: 31,870.25 | transaction_form_type: 4
• Holds 0 shares of Common Stock (Direct)
  Date: 2025-12-12 | Code: H | nature_of_ownership: 401(k) | shares_owned_after: 38,817.70
• Holds 0 shares of Common Stock (Direct)
  Date: 2025-12-12 | Code: H | nature_of_ownership: By Trust | shares_owned_after: 135,152.00

Footnotes:

• REMARKS: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.